Corbus Pharmaceuticals Hldgs Inc CRBP

$2.43 -0.31 (-11.29%)

Valuation

Market cap
62,027,000
Revenue TTM
$0
Net income TTM
$-78,540,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
660,400
Avg volume
1,209,524
Day's range
$2.41 – $2.88
Shares out
20,607,000
Stochastic %K
8%
Beta
2.80
Analysts
Strong Buy
Price target
$32.67

Price

Company profile

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The...

Show more

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 963 0100
Website
https://www.corbuspharma.com
Address
500 River Ridge Drive, Norwood, United States

Latest news

Stocktwits

birdmine Nov 19, 7:52 PM
$CRBP I advise everyone that is still stuck in this stock get out. It’s depreciating every day and I don’t see an end. Good luck!
0 replies
birdmine Nov 19, 3:47 PM
$CRBP trash
0 replies
birdmine Nov 19, 3:40 PM
$CRBP locked in a price target that hit and it still hasn’t sold. This company is tanking.
0 replies
birdmine Nov 19, 8:46 AM
$CRBP do hedgefunds buy stock and then short it Yes, hedge funds regularly both buy ("go long") and short sell stocks—sometimes even on the same stock or within the same sector. How Hedge Funds Use Buying and Shorting • Long/Short Equity: Hedge funds often buy stocks expected to rise while shorting stocks expected to fall. A common approach is pairing a strong company (long) with a weaker rival in the same sector (short) to reduce broad market risk. • Hedging Existing Positions: A fund may open a short position to offset potential short-term losses on a long position it already holds. • Flipping From Long to Short: If a fund buys a stock and its thesis changes—such as worsening fundamentals or a price spike—it can sell its long shares and later borrow shares to short the stock if it expects a decline.
0 replies
Pne01 Nov 19, 7:17 AM
$CRBP RA capital bought 9,9% of Corbus AFTER the obesity readout 14 sept. MPM BioImpact bought more and reported a 8,6% position AFTER the obesity readout 14 sept. Does this mean they love CRB-913? Maybe not, rather they are in it for CRB-701. They both have an avarage buying price above 7$. No matter how the obesity asset plays out, these two firms belive Corbus is worth way more then 7$. Now we trade under 3$. 2027 will be a great year I'm certain.
0 replies
birdmine Nov 18, 4:49 PM
$CRBP this is rushing to reverse split territory. I’m going to have to jump.
0 replies
birdmine Nov 18, 3:14 PM
$CRBP I didn’t think that they would actually run this company into the ground!! I was sooo wrong!!!
1 replies
birdmine Nov 18, 2:53 PM
$CRBP I should have dropped this last year. This has been the biggest thorn in my side!!!
0 replies